Ignite Creation Date:
2025-12-25 @ 4:54 AM
Ignite Modification Date:
2026-04-14 @ 5:32 PM
Study NCT ID:
NCT05622318
Status:
SUSPENDED
Last Update Posted:
2025-10-21
First Post:
2022-11-11
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
De-escalated Cyclophosphamide (PTCy) and Ruxolitinib for Graft-versus-Host Disease (GVHD) Prophylaxis
Sponsor:
Medical College of Wisconsin
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
PRO00046962
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None